Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Apexigen, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 17 | 15 | −2 |
| Shares | 3.14M | 3.16M | +21.7K (+0.7%) |
| Value | $8.48M | $2.16M | −$6.32M (−74.5%) |
New holders (3)
Institutions that held Apexigen, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mercer Global Advisors Inc | 43,626 | $30.0K | 0.00% |
| Destination Wealth Management | 13,216 | $9.01K | 0.00% |
| Susquehanna International Group, LLP | 11,851 | $8.18K | 0.00% |
Sold out (5)
Institutions that held Apexigen, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Two Sigma Investments, LP | 13,934 | $38.0K |
| Fifth Third Bancorp | 1,500 | $4.00K |
| Advisor Group Holdings, Inc. | 200 | $1.00K |
| Morgan Stanley | 49 | $0 |
| Simplex Trading, LLC | 196 | $0 |